MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

BOLD Boundless Bio Forecast, Technical & Fundamental Analysis

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology
BOLD
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For BOLD
(Try 14 days for $1 only)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BOLD
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For BOLD
(Try 14 days for $1 only)
Ad is loading...
A.I. Advisor
published Earnings

BOLD is expected to report earnings to fall 5.19% to -73 cents per share on November 27

Boundless Bio BOLD Stock Earnings Reports
Q3'24
Est.
$-0.73
Q2'24
Missed
by $0.12
The last earnings report on August 12 showed earnings per share of -76 cents, missing the estimate of -64 cents. With 212.48K shares outstanding, the current market capitalization sits at 76.11M.
A.I. Advisor
published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFAMX30.19N/A
N/A
JPMorgan Emerging Markets Equity A
PDECX15.25N/A
N/A
PGIM Jennison Emerging Markets Eq Opps C
ESMCX14.87-0.04
-0.27%
Invesco EQV Euro Small Company C
FDGIX24.26-0.10
-0.41%
Fidelity Advisor Dividend Growth I
MRJAX11.26-0.05
-0.44%
Morgan Stanley Multi-Asset Real Return A

BOLD and Stocks

Correlation & Price change

A.I.dvisor tells us that BOLD and TNXP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLD and TNXP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
+1.46%
TNXP - BOLD
31%
Poorly correlated
-1.29%
KOD - BOLD
30%
Poorly correlated
-1.12%
GRI - BOLD
25%
Poorly correlated
-2.84%
AKBA - BOLD
23%
Poorly correlated
-0.73%
CLSD - BOLD
10%
Poorly correlated
+0.38%
More